Table 1 Demographics and baseline clinical profile
From: The effect of hyperlactatemia timing on the outcomes after cardiac surgery
Variable | Early hyperlactatemia | ||
|---|---|---|---|
No | Yes | P value | |
No. of patients | (253) | (52) | |
Age (years) | 54.3 ± 12.8 | 53.6 ± 14.9 | 0.79 |
BSA | 1.84 ± 0.29 | 1.88 ± 0.22 | 0.45 |
BMI | 29.3 ± 6.6 | 30.4 ± 7.4 | 0.32 |
Female | 37.5% (95) | 42.3% (22) | 0.52 |
Euro Score ES II | 3.5 ± (4.5) | 3.6 ± (4.8) | 0.94 |
Diabetes mellitus | 51.4% (129) | 30% (15) | 0.006 |
Metformin use | 24.5% (62) | 15.4% (8) | 0.15 |
Hypertension | 53.6% (134) | 54% (27) | 0.96 |
Creatinine clearance | 97.1 ± 38.5 | 99.8 ± 42.3 | 0.52 |
ESRD on dialysis | 2.4% (6) | 4% (2) | 0.50 |
Operation category | 0.038 | ||
Isolated CABG | 35.2% (89) | 23.1% (12) | |
Isolated valve(s)a | 49.2% (124) | 50% (26) | |
Combined CABG + valve(s)a | 9.5% (24) | 21.2% (11) | |
Othersb | 6% (15) | 5.8% (3) | |
Cardioplegia type | 0.96 | ||
Del Nido | 75.8% (191) | 75.5% (40) | |
Cold blood | 24.2% (61) | 24.5% (13) | |
Atrial Fibrillation | 19.1% (48) | 22% (11) | 0.64 |
Ejection Fraction | 50.1 ± (9.4) | 49.4 (9.8) | 0.64 |
Redo surgery (first and multiple) | 11.1% (28) | 7.7% (4) | 0.47 |
Preoperative TIA or stroke | 4% (10) | 4% (2) | 0.50 |
Systolic PAP (mmHg) | 38.5 ± 17 | 36.8 ± 15.6 | 0.57 |
Hemoglobin (mg/dL) | 12.3 ± 2.2 | 12 ± 1.9 | 0.40 |